Linike Medical Group Ltd (LNMG)
USD 0.13
(13.64%)
USD 0.13
(13.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2013 | 2012 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.25 Million | -19.14 Thousand | -22.01 Thousand | -20.82 Thousand | -28.48 Thousand | -81.98 Thousand |
| Net Income | 991.04 Thousand | -65.97 Thousand | -29.86 Thousand | -88.56 Thousand | -427.76 Thousand | -88.35 Thousand |
| Depreciation & Amortization | 65.11 Thousand | - | - | - | 593.00 | 2163.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -3.31 Million | 7991.00 | 7849.00 | -2462.00 | 398.69 Thousand | 4205.00 |
| Other non-cash items | 3.29 Million | 38.84 Thousand | - | 70.2 Thousand | -93.74 Thousand | 121.00 |
| Investing Cash Flow | -58.78 Thousand | - | - | - | - | - |
| Investments in PPE | -58.78 Thousand | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 2.04 Million | 19.14 Thousand | 23.42 Thousand | 20.73 Thousand | 16.22 Thousand | 11.88 Thousand |
| Debt repayment | -2.04 Million | -19.14 Thousand | -23.42 Thousand | -20.73 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -3.00 | - | - | - | 16.22 Thousand | 11.88 Thousand |
| Accounts receivables | -2.24 Million | - | - | - | 925.00 | - |
| Accounts payables | -915.28 Thousand | - | - | - | 94 Thousand | 7523.00 |
| Inventory | - | - | - | - | - | -3318.00 |
| Other working capital | -149.25 Thousand | 7991.00 | 7849.00 | -2462.00 | 303.76 Thousand | - |
| Cash at beginning of period | 1413.00 | 1143.00 | -270.00 | - | 27.85 Thousand | 97.95 Thousand |
| Cash at end of period | 789.41 Thousand | 1413.00 | 1143.00 | -91.00 | 2586.00 | 27.85 Thousand |
| Capital Expenditure | -58.78 Thousand | - | - | - | - | - |
| Effect of forex changes on cash | 1.00 | - | - | - | 12.86 | - |
| Net cash flow / Change in cash | 787.99 Thousand | 270.00 | 1413.00 | -91.00 | -25.26 Thousand | -70.1 Thousand |
| Free Cash Flow | -2.31 Million | -19.14 Thousand | -22.01 Thousand | -20.82 Thousand | -28.48 Thousand | -81.98 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -480.89 Thousand | -694.55 Thousand | 711.64 Thousand | 266.96 Thousand | 991.04 Thousand | 211.88 Thousand |
| Depreciation & Amortization | 18.31 Thousand | - | 94.91 Thousand | 30.95 Thousand | 65.11 Thousand | 15.7 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 747.59 Thousand | 1.01 Million | -1.06 Million | 286.61 Thousand | -3.31 Million | -1.14 Million |
| Other non-cash items | -618.6 Thousand | -1.74 Million | 1.66 Million | -281.96 Thousand | 3.29 Million | 1.2 Million |
| Investing Cash Flow | - | -13.95 Thousand | -891.00 | - | -58.78 Thousand | -53.3 Thousand |
| Investments in PPE | 1.00 | -13.95 Thousand | -891.00 | - | -58.78 Thousand | -53.3 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.22 Million | -1.61 Million | 718.17 Thousand | -227.51 Thousand | 2.04 Million | -93.27 Thousand |
| Debt repayment | -1.22 Million | -1.61 Million | -718.17 Thousand | -227.51 Thousand | -2.04 Million | -93.27 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | -3.00 | - |
| Accounts receivables | -463.95 Thousand | -346.82 Thousand | -109.67 Thousand | 11.08 Thousand | -2.24 Million | 1.28 Million |
| Accounts payables | 1.11 Million | 2.02 Million | -1.36 Million | 332.78 Thousand | -915.28 Thousand | -2.45 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 92.36 Thousand | -663.55 Thousand | 411.68 Thousand | -57.24 Thousand | -149.25 Thousand | 21.04 Thousand |
| Cash at beginning of period | 136.26 Thousand | 82.29 Thousand | 789.41 Thousand | 432.4 Thousand | 1413.00 | 785.24 Thousand |
| Cash at end of period | 1.64 Million | 136.26 Thousand | 82.29 Thousand | 789.41 Thousand | 789.41 Thousand | 432.4 Thousand |
| Capital Expenditure | 1.00 | -13.95 Thousand | -891.00 | - | -58.78 Thousand | -53.3 Thousand |
| Effect of forex changes on cash | - | - | -1.16 Million | - | 1.00 | 714.98 Thousand |
| Net cash flow / Change in cash | 1.5 Million | 53.97 Thousand | -707.11 Thousand | 357.01 Thousand | 787.99 Thousand | -352.84 Thousand |
| Free Cash Flow | 285.02 Thousand | 231.87 Thousand | -262.04 Thousand | 584.53 Thousand | -2.31 Million | -974.55 Thousand |
2337
FFLO
IDA
MEDICAPQ
9325
VS